Trial Profile
A PHASE I, RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED, SINGLE-ASCENDING DOSE STUDY TO INVESTIGATE THE SAFETY,TOLERABILITY, AND PHARMACOKINETICS OF DSTA4637S IN HEALTHY VOLUNTEERS
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2020
Price :
$35
*
At a glance
- Drugs DSTA 4637S (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions; First in man
- Sponsors Genentech
- 25 Oct 2020 Results comparing Pharmacokinetics of DSTA4637S in Patients with Staphylococcus aureus Bacteremia Receiving Standard-of-Care Antibiotics with Pharmacokinetics in Healthy Volunteers, presented at the IDWeek 2020
- 25 Mar 2019 Results published in the Antimicrobial Agents and Chemotherapy
- 03 Oct 2016 Status changed from recruiting to completed.